Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis

Menopause

Volumn 22, Issue 4, 2015, Pages 391-401

  Hodis, Howard N ^a,b   Mack, Wendy J ^a   Shoupe, Donna ^a   Azen, Stanley P ^a   Stanczyk, Frank Z ^a   Hwang Levine, Juliana ^a,b   Budoff, Matthew J ^c   Henderson, Victor W ^d  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d STANFORD UNIVERSITY   (United States)

Author keywords

Cardiovascular disease; Cognition; Estrogen; Hormone therapy; Menopause; Postmenopause; Randomized trials; Timing hypothesis; Women

Indexed keywords

CREATININE; ESTRADIOL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PROGESTERONE; SEX HORMONE BINDING GLOBULIN; TRIACYLGLYCEROL; ESTROGEN; LIPID;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; ATHEROSCLEROSIS; BLOOD; BLOOD PRESSURE; DIAGNOSTIC IMAGING; DRUG EFFECTS; ORAL DRUG ADMINISTRATION; PATHOLOGY; PROCEDURES; TIME FACTOR; X-RAY COMPUTED TOMOGRAPHY;

ADMINISTRATION, ORAL; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY MASS INDEX; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; CORONARY ARTERY DISEASE; DOUBLE-BLIND METHOD; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; LIPIDS; MENOPAUSE; RISK FACTORS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84927039506     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0000000000000343     Document Type: Article

References (34)

1. Hodis HN, Mack WJ,. The timing hypothesis and hormone replacement therapy: a paradigm shift in the primary prevention of coronary heart disease in women, 1: comparison of therapeutic efficacy. J Am Geriatr Soc 2013; 61: 1005-1010
2. Hodis HN, Mack WJ,. The timing hypothesis and hormone replacement therapy: a paradigm shift in the primary prevention of coronary heart disease in women, 2: comparative risks. J Am Geriatr Soc 2013; 61: 1011-1018
3. Henderson VW,. Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research. Neuroscience 2006; 138: 1031-1039
4. MacLennan AH, Henderson VW, Paine BJ, Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study. Menopause 2006; 13: 28-36
5. Hodis HN, Mack WJ, Lobo RA, Estrogen in the prevention of atherosclerosis: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001; 135: 939-953
6. Hodis HN, Mack WJ, Lobo RA, Hormone therapy and progression of coronary artery atherosclerosis in postmenopausal women. N Engl J Med 2003; 349: 535-545
7. Clarkson TB,. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression. Menopause 2007; 14: 373-384
8. Rosenfeld ME, Kauser K, Martin-McNulty B, Polinsky P, Schwartz SM, Rubanyi GM,. Estrogen inhibits the initiation of fatty streaks throughout the vasculature but does not inhibit intra-plaque hemorrhage and the progression of established lesions in apolipoprotein E deficient mice. Atherosclerosis 2002; 164: 251-259
9. Tarhouni K, Guihot AL, Vessieres E, Determinants of flow-mediated outward remodeling in female rodents: respective roles of age, estrogens, and timing. Arterioscler Thromb Vasc Biol 2014; 34: 1281-1289
10. Rossouw JE, Prentice RL, Manson JE, Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007; 297: 1465-1477
11. Henderson VW, St John JA, Hodis HN, Cognition, mood, and physiological concentrations of sex hormones in the early and late postmenopause. Proc Natl Acad Sci 2013; 110: 20290-20295
12. Probst-Hensh NM, Ingles SA, Diep AT, Aromatase and breast cancer susceptibility. Endocr Relat Cancer 1999; 6: 165-173
13. Little RR, Rohlfing CL, Sacks DB, National Glycohemoglobin Standardization Program (NGSP) Steering Committee. Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care. Clin Chem 2011; 57: 205-214
14. Hunter MS,. The Women's Health Questionnaire (WHQ): frequently asked questions (FAQ). Health Qual Life Outcomes 2013; 1: 41
15. Hodis HN, Mack WJ, LaBree L, Tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS). Circulation 2002; 106: 1453-1459
16. Selzer RH, Hodis HN, Kwong-Fu H, Evaluation of computerized edge tracking for quantifying intima-media thickness of the common carotid artery from B-mode ultrasound images. Atherosclerosis 1994; 111: 1-11
17. Selzer RH, Mack WJ, Lee PL, Kwong-Fu H, Hodis HN,. Improved common carotid elasticity and intima-media thickness measurement from computer analysis of sequential ultrasound frames. Atherosclerosis 2001; 154: 185-193
18. Henderson VW, St John JA, Hodis HN, Long-Term soy isoflavone supplementation and cognition in women: a randomized, controlled trial. Neurology 2012; 78: 1841-1848
19. Carr JJ, Nelson JC, Wong ND, Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. Radiology 2005; 234: 35-43
20. Budoff MJ, Dowe D, Jollis JG, Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) Trial. J Am Coll Cardiol 2008; 52: 1724-1732
21. Grodstein F, Stampfer M,. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiol Dis 1995; 38: 199-210
22. Grodstein F, Stampfer M,. Estrogen for women at varying risk of coronary disease. Maturitas 1998; 30: 19-26
23. Schierbeck LL, Rejnmark L, Tofteng CL, Effect of hormone replacement treatment on cardiovascular events in recently postmenopausal women: randomized trial. BMJ 2012; 345: e6409
24. Karim R, Mack WJ, Lobo RA, Determinants of the effect of estrogen on the progression of subclinical atherosclerosis: Estrogen in the Prevention of Atherosclerosis Trial. Menopause 2005; 12: 366-373
25. Karim R, Hodis HN, Stanczyk FZ, Lobo RA, Mack WJ,. Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women. J Clin Endocrinol Metab 2008; 93: 131-138
26. Salpeter SR, Walsh JME, Greyber E, Salpeter EE,. Coronary heart disease events associated with hormone therapy in younger and older women: a meta-Analysis. J Gen Intern Med 2006; 21: 363-366
27. Salpeter SR, Walsh JME, Greyber E, Ormiston TM, Salpeter EE,. Mortality associated with hormone replacement therapy in younger and older women: a meta-Analysis. J Gen Intern Med 2004; 19: 791-804
28. Salpeter SR, Cheng J, Thabane L, Buckley NS, Salpeter EE,. Bayesian meta-Analysis of hormone therapy and mortality in younger postmenopausal women. Am J Med 2009; 12: 1016-1022
29. LaCroix AZ, Chlebowski RT, Manson JE, Health outcomes after stopping conjugated equine estrogens among postmenopausal women with hysterectomy: a randomized controlled trial. JAMA 2011; 305: 1305-1314
30. Collins P, Mosca L, Geiger MJ, Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for the Heart trial: results of subgroup analyses by age and other factors. Circulation 2009; 119: 922-930
31. Salpeter SR, Buckley NS, Liu H, Salpeter EE,. The cost-effectiveness of hormone therapy in younger and older postmenopausal women. Am J Med 2009; 122: 42-52
32. Manson JE, Allison MA, Rossouw JE, Estrogen therapy and coronary-Artery calcification. N Engl J Med 2007; 356: 2591-2602
33. Hodis HN, Mack WJ, Kono N, Isoflavone soy protein supplementation and progression of subclinical atherosclerosis in healthy postmenopausal women: a randomized controlled trial. Stroke 2011; 42: 3168-3175
34. Sherwin BB,. Estrogen therapy: is time of initiation critical for neuroprotection? Nat Rev Endocrinol 2009; 5: 620-627